Santos Bevétel Y / Y
Mi az Santos Bevétel Y / Y?
A Bevétel Y / Y az Santos Ltd. - 71.30%
Mi a Bevétel Y / Y meghatározása?
Az elmúlt 3 évben az éves bevételnövekedés a bevételek növekedése az elmúlt 3 év átlagában az elmúlt 3 évben.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Bevétel Y / Y a Energy szektor a OTC-on cégekben a Santos -hoz képest
Mit csinál Santos?
Santos Limited explores for, develops, produces, transports, and markets hydrocarbons for homes and businesses in Australia and the Asia Pacific. Its five principal assets are located in the Cooper Basin, Queensland and NSW, Papua New Guinea, Northern Australia and Timor-Leste, and Western Australia. The company also holds an asset in Alaska; and engages in the development of carbon capture and storage technologies. In addition, it produces natural gas, liquefied petroleum gas, ethane, methane, coal seam gas, liquefied natural gas, shale gas, and condensate, as well as oil. The company's proved plus probable reserves include 1676 million barrels of oil equivalent. Santos Limited was incorporated in 1954 and is headquartered in Adelaide, Australia.
bevétel y / y -hoz hasonló cégek Santos
- BeiGene nak Bevétel Y / Y 71.00% van
- BeiGene Ltd nak Bevétel Y / Y 71.01% van
- Satia Industries nak Bevétel Y / Y 71.02% van
- Aegis Logistics nak Bevétel Y / Y 71.05% van
- abrdn Australia Equity Fund Inc nak Bevétel Y / Y 71.05% van
- Rushil Decor nak Bevétel Y / Y 71.09% van
- Santos nak Bevétel Y / Y 71.30% van
- Honda Siel Power Products nak Bevétel Y / Y 71.31% van
- Cairn Homes plc nak Bevétel Y / Y 71.36% van
- Kymera Therapeutics nak Bevétel Y / Y 71.38% van
- Stoke Therapeutics nak Bevétel Y / Y 71.38% van
- First Citizens BancShares nak Bevétel Y / Y 71.48% van
- Sanara MedTech nak Bevétel Y / Y 71.51% van